Table: Ono Pharm -2021/22 group results (IFRS)

ONO PHARMACEUTICAL

11/05/2022 04:00

May 11 (Reuters)- 
              Ono Pharmaceutical Co Ltd 
              CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified) 
                   Year ended      Year ended       Year to        NEXT  
                Mar 31, 2022    Mar 31, 2021   Mar 31, 2023      YEAR    
                   LATEST         YEAR-AGO        COMPANY      COMPANY   
                   RESULTS         RESULT        FORECAST    H1 FORECAST 
  Sales            361.36          309.28                                
                 (+16.8 pct)     (+5.8 pct)                              
  Sales                                           425.00                 
                                                (+17.6 pct)              
  Operating        103.20           98.33         145.00                 
                 (+4.9 pct)      (+26.9 pct)    (+40.5 pct)              
  Pretax           105.03          100.89         146.00                 
                 (+4.1 pct)      (+26.6 pct)    (+39.0 pct)              
  Net               80.52           75.43         110.00                 
                 (+6.8 pct)      (+26.3 pct)    (+36.6 pct)              
  EPS Basic      162.19 yen      151.11 yen     225.30 yen               
  EPS Diluted    162.16 yen      151.09 yen                              
  Ann Div         56.00 yen       50.00 yen      66.00 yen               
  -Q2 Div         28.00 yen       22.50 yen      33.00 yen               
  -Q4 Div         28.00 yen       27.50 yen      33.00 yen               
 
  NOTE - Ono Pharmaceutical Co Ltd. 
  (Figures are reported based on international accounting rules (IFRS).) 
  If there is no Q1 or Q3 dividend, Q2 will in most cases correspond to the first-half 
  dividend and Q4 to the second-half dividend announced before a new corporate law in 
  2006 allowed companies to pay and report dividends on a quarterly basis.
  *Net - represents Net profit attributable to owners of the parent company.
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4528.T